Cargando…
Understanding caregiver descriptions of initial signs and symptoms to improve diagnosis of metachromatic leukodystrophy
BACKGROUND: Metachromatic leukodystrophy (MLD), a relentlessly progressive and ultimately fatal condition, is a rare autosomal recessive lysosomal storage disorder caused by a deficiency of the enzyme arylsulfatase A (ARSA). Historically management has been palliative or supportive care. Hematopoiet...
Autores principales: | Eichler, F., Sevin, Caroline, Barth, M., Pang, F., Howie, K., Walz, M., Wilds, A., Calcagni, C., Chanson, C., Campbell, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531467/ https://www.ncbi.nlm.nih.gov/pubmed/36195888 http://dx.doi.org/10.1186/s13023-022-02518-z |
Ejemplares similares
-
An international study of caregiver-reported burden and quality of life in metachromatic leukodystrophy
por: Sevin, Caroline, et al.
Publicado: (2022) -
Intrathecal baclofen in metachromatic leukodystrophy
por: van der Veldt, Nikki, et al.
Publicado: (2018) -
Modified Delphi procedure-based expert consensus on endpoints for an international disease registry for Metachromatic Leukodystrophy: The European Metachromatic Leukodystrophy initiative (MLDi)
por: Schoenmakers, Daphne H., et al.
Publicado: (2022) -
Insights into the natural history of metachromatic leukodystrophy from interviews with caregivers
por: Harrington, Magdalena, et al.
Publicado: (2019) -
Diffusion tensor imaging in metachromatic leukodystrophy
por: van Rappard, Diane F., et al.
Publicado: (2018)